Dr. Siao-Yi Wang

Claim this profile

University of California Davis Comprehensive Cancer Center

Studies Relapse
Studies Thyroid Cancer
3 reported clinical trials
6 drugs studied

Area of expertise

1Relapse
Siao-Yi Wang has run 2 trials for Relapse. Some of their research focus areas include:
Stage IV
PD-L1 positive
p16 positive
2Thyroid Cancer
Siao-Yi Wang has run 2 trials for Thyroid Cancer. Some of their research focus areas include:
Stage IV
PD-L1 positive
p16 positive

Affiliated Hospitals

Image of trial facility.
University Of California Davis Comprehensive Cancer Center
Image of trial facility.
Loyola Medicine Homer Glen

Clinical Trials Siao-Yi Wang is currently running

Image of trial facility.

Relatlimab + Immunotherapy

for Nasopharyngeal Cancer

This phase II trial tests the addition of BMS-986016 (relatlimab) to the usual immunotherapy after initial treatment for nasopharyngeal cancer that has come back after a period of improvement (recurrent) or that has spread from where it first started (primary site) to other places in the body (metastatic). Relatlimab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. The usual approach of treatment is initial treatment with chemotherapy such as the combination of cisplatin (or carboplatin) and gemcitabine, along with immunotherapy such as nivolumab. After the initial treatment is finished, patients may continue to receive additional immunotherapy. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Gemcitabine is a chemotherapy drug that blocks the cells from making deoxyribonucleic acid (DNA) and may kill cancer cells. Giving BMS-986016 in addition to the usual immunotherapy after initial treatment may extend the time without the tumor cells growing or spreading longer than the usual approach in patients with recurrent or metastatic nasopharyngeal cancer.
Recruiting1 award Phase 210 criteria

More about Siao-Yi Wang

Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Siao-Yi Wang has experience with
  • Atezolizumab
  • Talazoparib
  • Ipatasertib
  • Pembrolizumab
  • Nivolumab
  • Relatlimab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Siao-Yi Wang specialize in?
Siao-Yi Wang focuses on Relapse and Thyroid Cancer. In particular, much of their work with Relapse has involved Stage IV patients, or patients who are PD-L1 positive.
Is Siao-Yi Wang currently recruiting for clinical trials?
Yes, Siao-Yi Wang is currently recruiting for 1 clinical trial in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that Siao-Yi Wang has studied deeply?
Yes, Siao-Yi Wang has studied treatments such as Atezolizumab, Talazoparib, Ipatasertib.
What is the best way to schedule an appointment with Siao-Yi Wang?
Apply for one of the trials that Siao-Yi Wang is conducting.
What is the office address of Siao-Yi Wang?
The office of Siao-Yi Wang is located at: University of California Davis Comprehensive Cancer Center, Sacramento, California 95817 United States. This is the address for their practice at the University of California Davis Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security